Probably some nervous holders exiting before the results. Volume suggests it is nothing big, but as an illiquid stock, large moves up or down are to be expected.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025